Log in to post a reply
Oct 20, 2020 11:22AM
There are three current trials at NIH using this type of technology that I had flagged (there may be more, but these are probably the first you should look at). They are all in the lab of Dr. Steven Rosenberg (famous guy for this -- think Judy Perkins) and I think they are all recruiting.
nct03412877 (this is administration of autologous T-celles genetically engineered)
nct01174121 (this is short term cultured autologous tumor infiltrating lymphocytes + keytruda)
nct04102436 (this is another T cell engineering trial using some kind of a system to express T cell receptors)
I'd look at all of them -- I think the one you are talking about is the middle one. All require some length of hospital stay.
Also, take a look at this one: NCT03272334 -- it's the UVA trial that I was looking at -- they do something similar but then they infuse some drug that they've come up with.
Hope this helps --
11/2003, ILC, Left, Stage IIIC, ER+/PR+, HER2-
6/2006, ILC, Stage IV, metastasized to other, ER+
5/2019, ILC, Stage IV, metastasized to liver, ER+/PR+, HER2-
7/31/2019 Ibrance (palbociclib)
Lymph node removal: Left, Sentinel; Mastectomy: Left, Right; Reconstruction (left): Pedicled TRAM flap; Reconstruction (right): Pedicled TRAM flap
Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone)
Lymph node removal; Mastectomy; Reconstruction (left): Pedicled TRAM flap; Reconstruction (right): Pedicled TRAM flap